Bupivacaine with Epinephrine Injection Shortage

• • Bupivacaine (with epinephrine 1:200,000) injection, Pfizer, 0.25%, 10 mL vial, 50 count, NDC 00409-9042-01
  • Bupivacaine (with epinephrine 1:200,000) injection, Pfizer, 0.25%, 30 mL vial, 100 count, NDC 00409-9042-17
  • Bupivacaine (with epinephrine 1:200,000) injection, Pfizer, 0.25%, 50 mL vial, 25 count, NDC 00409-9043-01
  • Bupivacaine (with epinephrine 1:200,000) injection, Pfizer, 0.5%, 10 mL vial, 50 count, NDC 00409-9045-01
  • Bupivacaine (with epinephrine 1:200,000) injection, Pfizer, 0.5%, 30 mL vial, 100 count, NDC 00409-9045-17
  • Bupivacaine (with epinephrine 1:200,000) injection, Pfizer, 0.5%, 50 mL vial, 25 count, NDC 00409-9046-01
  • Marcaine (with epinephrine 1:200,000) injection, Pfizer, 0.25%, 10 mL vial, 10 count, NDC 00409-1746-10
  • Marcaine (with epinephrine 1:200,000) injection, Pfizer, 0.25%, 30 mL vial, 10 count, NDC 00409-1746-30
  • Marcaine (with epinephrine 1:200,000) injection, Pfizer, 0.25%, 50 mL vial, 1 count, NDC 00409-1752-50
  • Marcaine (with epinephrine 1:200,000) injection, Pfizer, 0.5%, 10 mL vial, 10 count, NDC 00409-1749-10
  • Marcaine (with epinephrine 1:200,000) injection, Pfizer, 0.5%, 30 mL vial, 10 count, NDC 00409-1749-29
  • Marcaine (with epinephrine 1:200,000) injection, Pfizer, 0.5%, 50 mL vial, 1 count, NDC 00409-1755-50
  • Sensorcaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.25%, 50 mL vial, 25 count, NDC 63323-0461-57
  • Sensorcaine (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.5%, 50 mL vial, 25 count, NDC 63323-0463-57
  • Sensorcaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.25%, 10 mL vial, 25 count, NDC 63323-0468-17
  • Sensorcaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.25%, 30 mL vial, 25 count, NDC 63323-0468-37
  • Sensorcaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.5%, 10 mL vial, 25 count, NDC 63323-0462-17
  • Sensorcaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.5%, 30 mL sterile pack vial, 5 count, NDC 63323-0462-31
  • Sensorcaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.5%, 30 mL vial, 25 count, NDC 63323-0462-37
  • Sensorcaine-MPF (with epinephrine 1:200,000) injection, Fresenius Kabi, 0.75%, 30 mL vial, 25 count, NDC 63323-0460-37

• • Fresenius Kabi has bupivacaine and epinephrine on shortage due to increased demand.
  • Pfizer has bupivacaine with epinephrine on shortage due to manufacturing delays.

• • There are no presentations available

Estimated Resupply Dates

• • Fresenius Kabi has 0.25% Sensorcaine-MPF with epinephrine 10 mL and 30 mL vials on back order and the company estimates a release date of 3rd quarter 2024. The 0.25% Sensorcaine with epinephrine 50 mL vials are on back order and the company estimates a release date of 3rd quarter 2024. The 0.5% Sensorcaine-MPF with epinephrine 10 mL and 30 mL vials are on back order and the company estimates a release date of 3rd quarter 2024. The 0.5% Sensorcaine with epinephrine 50 mL vials are on back order and the company estimates a release date of 3rd quarter 2024. The 0.5% Sensorcaine-MPF with epinephrine 30 mL sterile packs are on back order and the company estimates a release date of 3rd quarter 2024. The 0.75% Sensorcaine-MPF with epinephrine 30 mL vials are on back order and the company estimates a release date of 3rd quarter 2024.
  • Pfizer has 0.25% bupivacaine with epinephrine 10 mL and 30 mL preservative-free vials on back order and the company estimates a release date of June 2025. The 0.25% bupivacaine with epinephrine 50 mL vials are on back order and the company estimates a release date of June 2025. The 0.5% bupivacaine with epinephrine 10 mL and 30 mL preservative-free vials are on back order and the company estimates a release date of June 2025. The 0.5% bupivacaine with epinephrine 50 mL vials are on back order and the company estimates a release date of April 2025.
  • Pfizer has 0.25% Marcaine with epinephrine 10 mL vials available via direct orders only. The 0.25% Marcaine with epinephrine 30 mL vials and 50 mL vials are available in limited supply. The 0.5% Marcaine with epinephrine 10 mL vials are available in limited supply. The 0.5% Marcaine with epinephrine 30 mL vials and 50 mL vials are on back order and the company estimates a release date of May 2024. All Marcaine with epinephrine presentations are only available via direct orders.